I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
(R)-1,4-Diazabicyclo[4.3.0]nonane is used as pharmaceutical intermediate.
Meier E.Freed; Allan R.Day. Syntheses of 1,4-Diazabicyclo[4.4.0]decanes, 1,4-Diazabicyclo[4.3.0]nonanes and 1,8-Diazabicyclo[4.3.0]nonanes. J. Org. Chem. 1960, 25, (12),2108-2113
Brian R. de Costa; Xiaoshu He; Joannes T.M.Linders; Celia Dominguez; Zi Qiang Gu; Wanda Williams; Wayne Bowen. Synthesis and evaluation of conformationally restricted N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamines at .sigma. receptors. 2. Piperazines, bicyclic amines, bridged bicyclic amines, and miscellaneous compounds. J. Med. Chem. 1993, 36, (16),2311-2320
Hazard Statements: H314-H318
Causes severe skin burns and eye damage. Causes serious eye damage.
Precautionary Statements: P260u-P303+P361+P353-P305+P351+P338-P301+P330+P331-P405-P501a
Do not breathe dusts or mists. IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.